60 Degrees Pharmaceuticals (SXTP) EPS (Basic) Growth (3y) (2025 - 2026)
60 Degrees Pharmaceuticals (SXTP) EPS (Basic) Growth (3y) (2025 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.52 Bn | 132.67 Bn | 2.84 Bn | 6.85% |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.55 Bn | 3.93 Bn | 11.71% |
| 3 | Argenx Se | 65.31 Bn | 60.13 Bn | 1.37 Bn | 64.84% |
| 4 | Moderna | 61.77 Bn | 56.64 Bn | 52.00 Mn | 18.44% |
| 5 | BeOne Medicines | 42.26 Bn | 37.16 Bn | 1.53 Bn | 37.21% |
| 6 | Alnylam Pharmaceuticals | 31.19 Bn | 27.88 Bn | 992.69 Mn | 36.73% |
| 7 | BioNTech SE | 28.71 Bn | 10.31 Bn | 668.28 Mn | -26.87% |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 67.51% |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - | -38.31% |
| 10 | 60 Degrees Pharmaceuticals | 2.97 Mn | 1.95 Mn | 56,798.00 | 86.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 83.53% |
| Dec 31, 2025 | 79.43% |
| Sep 30, 2025 | 74.16% |
| Jun 30, 2025 | 72.21% |